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Abstract
Background: Mental disorders are associated with high costs for productivity loss, sickness absence and unemployment.
A participatory supportive return to work (RTW) program was developed in order to improve RTW among workers
without an employment contract, sick-listed due to a common mental disorder. The program contained a
participatory approach, integrated care and direct placement in a competitive job. The aim of this study was
to evaluate the cost-effectiveness and cost-utility of this new program, compared to usual care. In addition, its
return on investment was evaluated.
Methods: An economic evaluation was conducted alongside a 12-month randomized controlled trial. A total of 186
participants was randomly allocated to the new program (n = 94) or to usual care (n = 92). Effect measures were the
duration until sustainable RTW in competitive employment and quality-adjusted life years (QALYs) gained. Costs included
intervention costs, medical costs and absenteeism costs. Registered data of the Dutch Social Security Agency were used
to assess the duration until sustainable RTW, intervention costs and absenteeism costs. QALYs and medical costs were
assessed using three- or six-monthly questionnaires. Missing data were imputed using multiple imputations. Cost-
effectiveness analysis and cost-utility analysis were conducted from the societal perspective. A return on investment
analysis was conducted from the social insurer’s perspective. Various sensitivity analyses were performed to assess the
robustness of the results.
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Results: The new program had no significant effect on the duration until sustainable RTW and QALYs gained.
Intervention costs and medical costs were significantly higher in the intervention group. From the societal perspective,
the maximum probability of cost-effectiveness for duration until sustainable RTW was 0.64 at a willingness to pay of
about €10 000/day, and 0.27 for QALYs gained, regardless of the willingness to pay. From the social insurer’s perspective,
the probability of financial return was 0.18.
Conclusions: From the societal perspective, the new program was neither cost-effective in improving sustainable RTW
nor in gaining QALYs. From the social insurer’s perspective, the program did not result in a positive financial return.
Therefore, the present study provided no evidence to support its implementation.
Trial registration: The trial was listed at the Dutch Trial Register (NTR) under NTR3563 on August 7, 2012.
Keywords: Cost-effectiveness evaluation, Cost-utility evaluation, Return on investment, Randomized controlled trial,
Societal perspective, Social insurer’s perspective, Return to work, Occupational healthcare, Common mental disorders,
Vulnerable workers
Background
Mental disorders are associated with high costs for the
individuals concerned, employers, the social security
system, and society as a whole. In Europe, the overall
cost of mental disorders is estimated at 3–4% of the
gross domestic product [1]. The majority of these costs
is made outside the healthcare sector and is related to
loss of potential labor supply, sickness absence, reduced
productivity at work, and unemployment [1, 2]. To illus-
trate, individuals with a severe mental disorder are 6 to
7 times less likely to be employed compared with indi-
viduals without such a disorder. The risk of unemploy-
ment is smaller when disorders are milder. Nevertheless,
individuals with mild to moderate mental disorders, also
known as common mental disorders (CMDs), are still 2
to 3 times less likely to be employed [1]. This is an im-
portant concern, as mental disorders are highly preva-
lent in the working-age population and around three
quarters of those affected by a mental disorder have a
CMD [1]. Moreover, several Dutch studies comparing
sick-listed workers without an employment contract
with sick-listed employees revealed that the former often
experience a worse health status and face more obstacles
for return to work (RTW) [3]. As a result, these workers
have an increased risk for long-term disability [4].
Despite the aforementioned association between mental
ill health and unemployment, until now most intervention
research aiming to improve work participation of workers
sick-listed due to a CMD have assumed the presence of a
workplace [5]. For this reason, the participatory supportive
RTW program was developed. The aim of this program
was to shorten the duration until RTW of workers
without an employment contract who are sick-listed
due to a CMD. This program was based on three best
practices in occupational healthcare (OHC): a participa-
tory approach, integrated care, and direct placement in
a competitive job [6].
We evaluated the effectiveness of this new participa-
tory supportive RTW program on the duration until
sustainable RTW, in comparison with usual OHC in the
Netherlands for sick-listed workers without an employ-
ment contract [7]. However, to make a business case for
or against the intervention it is also important to evalu-
ate the (additional) societal cost per unit of effect gained
[8]. As decision-makers are often confronted with
limited resources, they need to decide on the optimal
allocation of resources to maximize a certain desired
outcome or benefit [9]. Therefore, the aim of the present
study was to conduct a cost-effectiveness analysis (CEA)
and a cost-utility analysis (CUA) to assess the (add-
itional) societal costs per one day earlier sustainable
RTW and per quality-adjusted life years (QALYs) gained.
In addition, we evaluated the financial return on invest-
ment (ROI) from the social insurer’s perspective. In the
Netherlands the Dutch Social Security Agency (SSA) is
responsible for sickness benefit payment and OHC for
sick-listed workers without an employment contract. Be-
cause of this, the SSA is interested in the financial return
of the new program. Our main research question was:
what was the cost-effectiveness and cost-utility of the
new participatory supportive RTW program from the
societal perspective, in comparison with usual OHC? A
second research question was: what was the ROI of the
new program, compared to usual OHC, from the social
insurer’s perspective?
Methods
Study population and design
An economic evaluation was conducted alongside a 12-
month randomized controlled trial (RCT), titled ‘The Co-
WORK study’, which took place between 2013 and 2015.
The trial was carried out in collaboration with seven of-
fices of the Dutch SSA, located in three districts, and with
three vocational rehabilitation agencies. Participants were
Lammerts et al. BMC Public Health  (2017) 17:162 Page 2 of 13
recruited via an invitational letter from the medical ad-
visor of the Dutch SSA. This invitational letter was sent
one to two weeks after sick-listing, so that an early inter-
vention could take place. This has been considered im-
portant in the prevention of long-term sickness absence
[10]. Because it was not possible to recruit on the basis of
a registered mental health complaint, every newly sick-
listed worker received an invitation. Sick-listed workers
were asked to only respond to this invitation when they
experienced mental health problems. Eligible for participa-
tion were workers sick-listed between two and 14 weeks,
who had applied for a sickness benefit at the Dutch
SSA due to the (partial) absence of an employment
contract, with mental health problems as the main rea-
son for their claim. Other inclusion criteria were: an
elevated level of distress, based on a distress screener
[11], and the intention to return to work despite
ongoing health complaints, as workers without this
intention less likely seem to benefit from a participatory
approach [12, 13].
Participants were randomly allocated to an intervention
or control group, after they had completed the baseline
questionnaire. Before randomization, pre-stratification took
place based on type of worker before sick-listing (i.e.
unemployed worker, temporary agency worker, and fixed-
term contract worker) and the three participating SSA dis-
tricts. Schemes with random permuted numbers were used
to create a block randomization table for each stratum,
with fixed block sizes of four. A research assistant
performed the randomization during an intake meeting
with the participant. Due to the nature of the inter-
vention, blinding participants and professionals for
the randomization result was not possible.
More information about the study design and setting,
in- and exclusion criteria for participation, recruitment
procedures, randomization and blinding, and the sample
size calculation can be found in the study protocol [6].
Interventions
Usual occupational healthcare
Usually, OHC is provided by a team of professionals
from the SSA consisting of an insurance physician, a
labor expert and a RTW coordinator. The OHC starts
with an examination of the sickness benefit claim by the
RTW coordinator. Subsequently, the RTW coordinator,
the insurance physician and the labor expert together
decide whether it is necessary for the sick-listed worker
to visit the insurance physician and/or the labor expert
for (medical) examination and/or advice on recovery and
RTW. If necessary, the sick-listed worker can be referred
to work disability oriented treatment or additional voca-
tional rehabilitation support. The OHC that is actually
delivered to the sick-listed worker is dependent on the
sick-listed worker’s progress in vocational rehabilitation.
The participatory supportive RTW program
All participants were entitled to usual OHC. In addition,
participants in the intervention group were referred to a
more protocolled form of OHC that started early after
sick-listing and contained several best practices. Two of
these practices, i.e. application of a participatory approach
and integrated care, were new and one of these practices,
i.e. placement in a competitive job by a vocational re-
habilitation agency, is also possible in usual OHC, but has
not been protocolled. Table 1 briefly describes the content
of this participatory supportive RTW program. A more
detailed description is presented in the study protocol [6].
Participating professionals were trained in the execution
Table 1 The participatory supportive RTW program
Examination of sickness benefit claim and medical problem analysis –
within two weeks after allocation to the intervention team
- The RTW coordinator examines the sickness benefit claim, conform
usual care
- The insurance physician makes a medical problem analysis, conform
usual care
Integrated care – directly after the medical problem analysis
- The insurance physician contacts the healthcare provider(s) of the sick-
listed worker by telephone to agree upon treatment and RTW, and to
stimulate cooperation during the vocational rehabilitation process
Participatory approach – within two weeks after the medical problem
analysis
- The labor expert supports the sick-listed worker and the RTW coordinator
separately in identifying and prioritizing obstacles for RTW
- The sick-listed worker and the RTW coordinator jointly search for solutions
to overcome the main obstacles for RTW, and discuss suitable work
- The labor expert tries to reach consensus between the sick-listed worker
and the RTW coordinator, and summarizes the consensus-based solutions
and suggestions for suitable work in a RTW action plan
- The insurance physician makes adjustments to the RTW action plan, if
necessary
- The labor expert sends the final action plan to all stakeholders
involved, and underlines the sick-listed worker’s own responsibility to
implement the action plan
Direct placement in a competitive job – within four weeks after making a
RTW action plan
- The RTW coordinator refers the sick-listed worker to a vocational
rehabilitation agency to facilitate the job search
- The vocational rehabilitation agency offers the sick-listed worker at
least two suitable competitive workplaces with a minimum contract
period of 3 months, matching the RTW action plan
- The sick-listed worker is placed in a suitable competitive workplace
Evaluation – within four weeks after making a RTW action plan
- The RTW coordinator contacts the sick-listed worker to evaluate the
implementation of the RTW action plan
- The RTW coordinator contacts the vocational rehabilitation agency to
inquire if the sick-listed worker has been placed in a suitable
workplace
- The sick-listed worker is referred to two other vocational rehabilitation
agencies for additional vocational support, if necessary
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of this program during one session of approximately two
and a half hours by the researchers, by means of a presen-
tation and role plays. Training sessions were organized for
each SSA office or district separately. In addition, follow-
up sessions were planned at each SSA office, to evaluate
the first cases and to discuss difficulties in applying the
program in daily practice.
Effect measures
Duration until sustainable RTW
The primary effect measure was duration until sustain-
able RTW in a competitive job, defined as the duration
in calendar days from the day of randomization until
(partial) work resumption for at least 28 calendar days in
a regular work setting for which payment is received at
the market rate [6]. When the participant was only par-
tially sick-listed, he was considered to have reached the
outcome when he had (partially) returned to work for
the hours he/she had been sick-listed for. For partici-
pants who had not reached the outcome, the total
follow-up time of 365 days was taken into account.
Data about paid employment is registered continu-
ously by the Dutch SSA, and was collected from this
database after one year follow-up. Every three months,
starting at baseline, questionnaires were used to collect
additional data on work resumption, to facilitate inter-
pretation of the registered data.
Quality-adjusted life years
At baseline, and after 6 and 12 months, the EuroQol-
5D-3 L [14] was used to assess quality of life. Scores on
the five ‘health dimension’ items (range 1–3) in this
questionnaire were translated into a utility score (on a
scale of 0–1, from equal to death to equal to full health)
using the Dutch tariff [14]. QALYs were calculated by
multiplying the obtained utility scores with the duration
in this health state, using linear interpolation between
measurement points.
Resource use and valuation
Intervention costs
Table 2 gives an overview of the applied cost categories
and corresponding unit prices for determining interven-
tion costs. Data on applied OHC during follow-up (i.e.
the number of consults with professionals from the
Dutch SSA and referrals by the SSA for additional sup-
port) were obtained from the SSA database. Consults
were valued using labor costs (including overhead) of
the SSA professionals. Costs for additional support were
valued using market prices, which were obtained from
the SSA database as well.
Costs for the training in the participatory supportive
RTW program were estimated using data on the number
and duration of provided training sessions, as well as
labor costs (including overhead) of SSA professionals
attending the sessions, and the researchers providing the
sessions.
Medical costs
Medical costs were assessed every three months using
The Trimbos/iMTA questionnaire for costs associated
with psychiatric illness (Tic-P) [15], measuring resource
use with a 3-month recall period. The questionnaire in-
cluded primary healthcare (i.e. consults with a general
practitioner, allied healthcare, and complementary medi-
cine), secondary healthcare (i.e. specialized healthcare, and
hospitalization) and the use of medication. As for the use
of medication, only the use of psychotropics, excluding
antipsychotics, was included. Healthcare utilization was
valued using Dutch Standard Costs [16] or, if not available,
prices according to the professional organizations. Prices
provided by the Dutch Society of Pharmacy [17] were used
to value medication use.
Absenteeism costs
From the societal perspective, absenteeism costs were
estimated by considering productivity loss. Because all
participants were (partially) unemployed at the time of
sick-listing, productivity loss could not be estimated
based on sickness absence days from work. Instead, our
starting point was the maximum number of productive
hours for a Dutch employee in full-time employment
(36 h/week), accounting for holidays and other days off,
which was 1540 h per year [16]. This number was
regarded as the maximally possible productivity loss.
The participants’ level of productivity loss was estimated
by subtracting the total number of hours in paid
Table 2 Assessment of intervention costs
Cost categories Unit prices
Applied OHC by the Dutch SSA –
Intervention and control group
Number of consults with OHC
professionals from the Dutch SSA
- RTW coordinator €58.50/h
- Insurance physician €106.20/h
- Labor expert €80.60/h
Referrals by the SSA to work disability
oriented treatment or additional vocational
rehabilitation support
Market price
Training in the participatory supportive
RTW program – Intervention group
Number of hours attending the
training
- RTW coordinator €58.50/h
- Insurance physician €106.20/h
- Labor expert €80.60/h
Number of hours providing the
training
- Junior researcher €33.30/h
- Senior researcher €67.90/h
- Professor €124.90/h
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employment during follow-up, obtained from the SSA
database, from the aforementioned maximum duration
of productivity loss. We used the Human Capital
Approach (HCA) to value productivity loss, by multi-
plying the loss of productivity in hours by the estimated
price of productivity loss for a Dutch worker per hour,
based on sex and age [16].
From the social insurer’s perspective, absenteeism
costs were calculated using the real costs for sickness
benefit and employment benefit payment during follow-
up, obtained from the SSA database.
All costs were converted to 2014 Euros using con-
sumer price indices [18]. As the follow-up of the trial
was one year, discounting of costs and effects was not
necessary.
Statistical analyses
Analyses were performed according to the intention-to-
treat principle. Statistical significance was set at p < 0.05.
Data were analyzed using Stata (V12, Stata Corp, College
Station, TX). Descriptive statistics were used to compare
baseline characteristics between the intervention and
control group, as well as between participants with
complete and incomplete data. Missing values for costs
and effects were imputed separately for the intervention
and control group using multiple imputations, through
Predictive Mean matching. In total, five complete data-
sets were created (loss of efficiency ≤ 5%) [19]. All of
the imputed datasets were analyzed as specified below,
after which pooled estimates were calculated using
Rubin’s rules [20].
Societal perspective: cost-effectiveness and cost-utility
analyses
The CEA and CUA were conducted from the societal
perspective, which means that all costs related to the
intervention were taken into account irrespective of who
pays or benefits. However, absenteeism costs were ex-
cluded from the CEA, as these costs could be considered
as a proxy for the effect measure (i.e. time to sustainable
RTW). Effect differences, in terms of duration until sus-
tainable RTW and QALYs, and cost differences between
the intervention and control group were analyzed simul-
taneously using seemingly unrelated regression (SUR).
Hereby, cost and effect difference estimates could be ad-
justed for their possible correlation [21]. Furthermore,
all estimates were corrected for possible prognostic fac-
tors for RTW as identified in the existing literature, i.e.
demographic characteristics, type of worker before sick-
listing, RTW expectation, RTW intention, fear avoidance
beliefs, and Attitude, Social influence and self-Efficacy
(ASE) regarding RTW [12, 13, 22–24]. All these possible
prognostic measures were assessed at baseline. Because
of the skewness of the cost data, 95% confidence
intervals (CIs) surrounding the cost-differences were es-
timated using bias-corrected and accelerated (BCA)
bootstrap intervals, with 5000 replications. Subsequently,
incremental cost-effectiveness ratios (ICERs) were calcu-
lated by dividing the corrected mean cost differences by
those in effects. By plotting bootstrapped incremental
cost-effect pairs (CE-pairs) on cost-effectiveness planes
(CE-planes), the uncertainty surrounding the ICERs was
graphically illustrated [25]. Cost-effectiveness acceptabil-
ity curves (CEACs) were plotted, presenting the inter-
vention’s probability of cost-effectiveness at different
values of willingness to pay [26].
Social insurer’s perspective: ROI analyses
ROI analyses were performed from the social insurer’s
perspective. Costs were defined as the mean difference
in intervention costs (i.e. differences in costs for applied
OHC and costs for the training in the participatory
supportive RTW program). Benefits were defined as the
mean difference in absenteeism costs between the inter-
vention and control group (i.e. the mean difference in
paid sickness benefits and unemployment benefits).
Positive benefits indicated reduced spending. Costs and
benefits were estimated using SUR analyses, and cor-
rected for the same possible confounders as described
above. The 95% CIs surrounding costs and benefits were
estimated using bias-corrected and accelerated (BCA)
bootstrap intervals, with 5000 replications. Three ROI-
metrics were calculated; 1) Net Benefits (NB), 2) Benefit
Cost Ratio (BCR), and 3) Return on Investment (ROI).
NB ¼ Benef its–Costs;BCR ¼ Benef its=Costs;ROI
¼ ððBenef its–CostsÞ=CostsÞ  100
Financial returns are positive when NB > 0, BCR > 1,
and ROI > 0% [27–29]. To quantify the precision of
these metrics, 95% bootstrapped confidence intervals
were estimated, using 5000 replications. Subsequently,
the probability of financial return was estimated based
on the proportion of bootstrapped NBs, BCRs, and/or
ROIs, indicating cost savings [30].
Sensitivity analyses
To assess the robustness of the results, five sensitivity
analyses (SA) were performed. First, analyses were per-
formed using the complete-cases only (SA1). Second,
analyses were performed excluding healthcare outliers,
i.e. cases in which expenses for secondary care were
above €10 000 (SA2). Third, per-protocol analyses were
performed, comparing intervention group participants
who had actually started with the participatory support-
ive RTW program after the medical assessment with
control group participants (SA3). Finally, for the CEA
and CUA only, two additional sensitivity analyses were
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performed in which the Friction Cost Approach (FCA)
was used instead of the HCA to value productivity loss.
According to this approach, organizations need a certain
period to replace a sick-listed worker (i.e. friction
period). When a sick-listed worker is replaced, product-
ivity loss stops. In the Netherlands, the estimated fric-
tion period was assumed to be 23 weeks [16]. More
recently, however, a friction period of 12 weeks has been
assumed [31]. We accounted for both friction periods,
which means that when productivity loss exceeded the
friction period of 23 or 12 weeks, costs were truncated
at the costs of 23 or 12 weeks of productivity loss in
SA4 and SA5, respectively.
Results
Participants
A total of 186 participants were randomly allocated to
the intervention (n = 94) or control group (n = 92). Fig. 1
illustrates the flow of participants in the Co-WORK
study. Data on QALYs were complete for 58% of partici-
pants (n = 107; 53 intervention group participants and 54
control group participants). Complete data on medical
costs was obtained for 47% of participants (n = 88; 43
intervention group participants and 45 control group par-
ticipants). Data on the primary effect measure and all
remaining cost categories were complete for all partici-
pants. Additional file 1: Table S1 presents the baseline
characteristics for intervention and control group partici-
pants with complete and incomplete baseline and follow-
up data. A relevant difference was found between the
RTW expectancy in the intervention and the control
group, indicating a more certain expectancy to RTW in
the control group. Relevant differences in age and the
intention to return to work were found between complete
and incomplete cases in both groups. In the control
group, more respondents with complete than incomplete
data still had an employment contract at baseline.
Effectiveness
Small and non-statistically significant differences in ef-
fects were found between the intervention and control
group. In the intervention group, sustainable RTW was
reached on average 6.6 days earlier (95%CI = −37.8–
24.6) compared with the control group, and the num-
ber of QALYs gained was on average 0.01 points lower
(95%CI = −0.08–0.06).
Costs
Additional file 2: Table S2 presents the cost differences
between the intervention and control group from the so-
cietal perspective. In the corrected model, average costs
for OHC consults, total intervention costs, secondary
care costs, total medical costs, and total societal costs
(excluding absenteeism costs) were significantly higher
in the intervention group.
Societal perspective
Cost-effectiveness
Additional file 3: Table S3 presents the results of the
cost-effectiveness and cost-utility analysis. For duration
until sustainable RTW, an ICER of -€487 was found, in-
dicating that a societal investment of €487 was needed
per one day earlier sustainable RTW. The majority of in-
cremental CE-pairs (67.3%) was located in the northeast
quadrant of the CE-plane (Additional file 3: Table S3,
Fig. 2), indicating that the intervention was on average
more costly and more effective. The wide distribution of
incremental CE-pairs in this plane illustrates a large level
of uncertainty around the cost-effectiveness estimate.
Figure 3 shows that when the willingness to pay for one
day earlier return to work is €0, the probability that the
participatory supportive RTW program can be consid-
ered cost-effective compared to usual OHC is about
zero. This probability increases with an increasing will-
ingness to pay, until it reaches a maximum probability
of about 0.64 at a willingness to pay of about €10 000.
Cost-utility
For QALYs, an ICER of -€125 357 was found, indicating
that a QALY lost was associated with a societal cost of
€125 357. This relatively large negative ICER was the re-
sult of a very small difference in QALYs gained between
the intervention and control group. The majority of in-
cremental CE-pairs (50.9%) was located in the northwest
quadrant of the CE-plane (Additional file 3: Table S3,
Fig. 4), indicating that the intervention was on average
more costly and less effective. A relatively large level of
uncertainty around the cost-utility estimate was visible.
Figure 5 illustrates that regardless of the willingness to
pay, the maximum probability of the new program being
cost-effective compared with usual OHC was about 0.27.
Social insurer’s perspective
Financial return
Additional file 4: Table S4 presents the results of the ROI
analysis. The total benefits from the social insurer’s per-
spective were on average -€784 (95%CI = €-3589–€1819),
indicating higher costs for sickness benefit and employ-
ment benefit payment in the intervention group compared
with the control group. The NB was on average -€1224
(95%CI = −€4048–€1503), suggesting a net loss for the
SSA of €1224 per intervention group participant. The
BCR was -€1.80 (95%CI = −€9.60–€6.50), which suggests
that each Euro invested in the participatory supportive
RTW program resulted in a loss of €1.80. The ROI was
−278% (95%CI = −1058–548), indicating a loss of 278%
per Euro invested. None of these estimates was statistically
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Non-response screening 
questionnaire (n=8058)
No inclusion in study (n=1578):
- Not willing to participate (n=941)
- Excluded based on in- and 
exclusion criteria (n=596)
- Unable to contact (n=18)
- Other (n=23)
Approached for 
participation in the study 
(n=9822)
Signed informed 
consent and completed 
baseline measurement  
(n=186)
INTERVENTION GROUP
Allocated to intervention & 
completed baseline measurement 
(n=94)
Assessed for eligibility 
(n=1764)
CONTROL GROUP
Allocated to control &
completed baseline measurement
(n=92)
Complete cases (n=73) Complete cases (n=74)
Complete cases (n=63) Complete cases (n=68)
Complete cases (n=64) Complete cases (n=62)






Complete follow-up: 42 ( 45%) 
Primary effect measure: 94 (100%)
QALYs: 53 (56%)
Medical costs: 43 (46%)





Complete follow-up: 44 (48%)
Primary effect measure: 92 (100%)
QALYs: 54 (59%)
Medical costs: 45 (49%)






Fig. 1 Flow of participants in the participatory supportive RTW program
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significant. The estimated maximum probability of finan-
cial return was 0.18, indicating a low probability of a posi-
tive return on investment.
Sensitivity analyses
Results of SA2, SA4 and SA5 were similar to those of the
main analyses, whereas the outcomes of SA1 and SA3
differed in some aspects from those of the main analyses or
contained useful additional information (Additional file 3:
Table S3). In SA1 (complete-case analyses), the average
difference in total societal costs (excluding absenteeism costs)
between both groups was no longer statistically significant. In
SA3 (per-protocol analyses), from the societal perspective, a
(not statistically significant) longer duration until sustainable
RTW was found in the per-protocol group (n= 36) compared
with the control group, whereas in the main analysis a (not
statistically significant) shorter duration was found for the
intervention group. Despite these differences, all sensitivity
analyses revealed a low probability of cost-effectiveness or fi-
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Fig. 3 CEAC for duration until sustainable RTW. CEAC indicating the probability of the intervention being cost-effective at different values (€) of
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Fig. 2 CE-plane for duration until sustainable RTW. CE-plane indicating the uncertainty around the ICER for duration until sustainable RTW
(societal perspective)
Lammerts et al. BMC Public Health  (2017) 17:162 Page 8 of 13
Discussion
This study evaluated the cost-effectiveness, cost-utility, and
return on investment of a participatory supportive RTW
program aimed at shortening the duration until sustainable
RTW of workers without an employment contract, sick-
listed due to a CMD, compared with usual OHC. From a
societal perspective, the program had no significant effect
on the duration until sustainable RTW and QALYs
gained. Intervention costs and medical costs were sig-
nificantly higher in the intervention group, resulting in
significantly higher total societal costs. The probability
of cost-effectiveness for both outcomes was relatively
low (i.e. a maximum probability of cost-effectiveness of
0.64 for the duration until sustainable RTW at a
willingness to pay of about €10 000 per day, and a
maximum probability of cost-effectiveness of 0.27 for
QALYs gained regardless of the willingness to pay).
Furthermore, from the social insurer’s perspective there
was a low probability of financial return. As such, the
present study does not provide evidence to implement
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Fig. 5 CEAC for QALYs gained. CEAC indicating the probability of the intervention being cost-effective at different values (€) of willingness to pay
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Fig. 4 CE-plane for QALYs gained. CE-plane indicating the uncertainty around the ICER for QALYs gained (societal perspective)
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Comparison with other studies
Over the past two decades, several economic evaluations
of similar participatory RTW programs were conducted
among different populations and settings [32–35]. An
economic evaluation conducted in a similar setting was
the study of Vermeulen et al. [35]. They evaluated a par-
ticipatory RTW program for temporary agency workers
and unemployed workers sick-listed due to musculoskel-
etal disorders. Their study revealed that a societal invest-
ment of €82 was needed per one day earlier sustainable
RTW, which was much lower than the ICER found in
the present study (i.e. €487/day). Furthermore, high
probabilities of cost-effectiveness at a low willingness to
pay were found in economic evaluations of a participa-
tory RTW program for employees with low back pain
[32, 33]. More in line with our findings were the results
from an economic evaluation of a participatory RTW
program for employees with distress by van Oostrom et
al. [34]. They found a low probability of the program be-
ing cost-effective in reducing time to sustainable RTW
compared with usual care from the societal perspective.
However, for a subgroup of their population with the
baseline intention to return to work despite symptoms,
the intervention was on average more effective and less
costly than usual care. Both the studies of Vermeulen et
al. [35] and van Oostrom et al. [34] revealed a low prob-
ability of the intervention being cost-effective in terms
of QALYs, as was also seen in the present study.
Differences between findings from the present study
and the aforementioned studies could be related to dif-
ferences in effectiveness of the interventions, which have
been discussed in more detail in our effectiveness evalu-
ation [7]. Also the large role of implementation failures
in the effectiveness of the participatory supportive RTW
program, such as the very low number of intervention
group participants that had actually started in the par-
ticipatory supportive RTW program (n = 36) and the low
protocol adherence within this ‘per-protocol group’, has
been discussed in our effectiveness evaluation [7]. The
present study, however, provides important new insights
into related costs. In the present study the mean costs
for applied OHC were highest in the intervention group,
but still lower than costs for applied OHC for the inter-
vention group in the study by Vermeulen et al. [35].
These higher costs in the study of Vermeulen et al. seem
to be (partly) related to the additional costs needed to
realize an early RTW, i.e. costs for rewarding a commer-
cially operating vocational rehabilitation agency, which
had been more successful in their study (19 versus nine
job placements) [36, 37]. Furthermore, in the present
study mean secondary care costs were significantly
higher in the intervention group compared to the con-
trol group, while in the study of Vermeulen et al. [35]
mean secondary care costs were highest in the control
group. However, the higher secondary care costs for the
intervention group were in line with the findings of Van
Oostrom et al. [34]. A post-hoc analysis following our
study indicated that in the intervention group during
follow-up more participants reported that they had received
specialized mental healthcare (n = 47; 50%) compared with
the control group (n = 37; 40.2%), i.e. consultations at an in-
stitute for specialized mental healthcare, treatment by a
psychologist/ psychiatrists/ psychotherapist, or (part-time)
day care for mental health complaints, although differences
were not statistically significant and data was not complete
for all participants.
Study implications
Although the findings from our post-hoc analysis should
be interpreted with caution, these findings may partly
explain the association between allocation to the new
participatory supportive RTW program and higher sec-
ondary care costs. An early focus on RTW may have
placed high demands on both participants and profes-
sionals involved, as the most common approach for sick-
listed workers with mental health problems is still to
‘train-and-place’ in (sheltered or volunteer) work [1].
Possibly, the prospect of RTW in a competitive job and
no longer being entitled to OHC and sickness benefit pay-
ment may have increased feelings of insecurity and stress
in these participants. Results of our previous qualitative
evaluation on the execution of the program in practice
also showed that many stakeholders expressed their
doubts on the feasibility of this early focus on RTW, and
suggested that often an increase of empowerment or men-
tal resilience was first needed [38]. This means that the
need for specialized (mental) healthcare possibly became
more prominent. Therefore, it may be worthwhile to con-
sider a more intensive and ongoing support by a multidis-
ciplinary team of professionals from the SSA, the (mental)
healthcare sector, and from a vocational rehabilitation
agency, and a more simultaneously focus on treatment
and vocational needs. From an economic perspective, fur-
ther research is necessary to investigate whether such an
approach could reduce secondary care costs without in-
creasing intervention costs.
In addition, for any future intervention for sick-listed
workers without an employment contract, it is important
to consider how costs needed to realize an early RTW in
the absence of a job to return to can remain low. In this
regard, Vermeulen et al. [35] proposed several measures,
such as realizing subsidized workplaces, increasing re-
sponsibilities of employers with regard to facilitation of
RTW, and creating a network of potential workplaces.
Very recently in the Netherlands, application of a no risk
policy for (ex) cancer patients without an employment
contract was considered. This policy compensates em-
ployers for sickness absence costs, in order to create an
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incentive for employers to hire particularly these workers
[39]. Future research is needed to assess whether such
measures may also contribute to a cost-effective RTW
program for workers without an employment contract,
sick-listed due to a CMD.
Strengths and limitations
This study provides insight into the costs of the partici-
patory supportive RTW program in relation to its ef-
fects. Although the program showed no beneficial or
adverse effect on the duration until sustainable RTW, in-
formation about its associated costs is needed to deter-
mine its probability of cost-effectiveness and financial
return. Moreover, reporting the probability of cost-
effectiveness and financial return of this program con-
tributes to unbiased systematic reviews on the resource
implications of these kind of interventions.
Another strength concerns the use of state-of-the-art
statistical measures, i.e. the use of multiple imputations,
SUR analyses and bootstrapping. This was one of the
first studies in which bootstrapping techniques were
not only used to estimate 95% CIs surrounding skewed
cost data, but also to estimate the level of uncertainty
around NB, BCR and ROI estimates, as well as the
probability of financial return, which is very useful for
decision-makers in OHC.
A third strength is the study’s pragmatic RCT design,
which made it possible to conduct an economic evalu-
ation in the ‘real-life’ setting. A disadvantage of this de-
sign is that caution is needed when generalizing the
results of this study to another jurisdiction.
A fourth strength concerns the use of registered data
by the SSA. Herewith, possible bias caused by self-
report, such as recall bias, was minimized. Furthermore,
data on RTW, applied OHC and paid benefits by the
SSA could be obtained for all participants. Consequently,
only five imputed datasets were needed to conduct the
analyses. Nevertheless, due to missing self-reported data
on QALYs and medical costs, data was complete for only
46% of participants. We dealt with this limitation by
using multiple imputations.
Another limitation of this study may be the assessment
of medication use. The self-reported data on medication
use were often difficult to interpret, as medication names
were misspelled or the brand name was used. To limit
bias, we chose to only consider the use of psychotropics
as these were easy to recognize, and the use of these medi-
cations was most likely to be affected by the intervention
under study.
A third limitation is that presenteeism during work
resumption was not taken into account, although pres-
enteeism costs can be high. However, a sophisticated
method for estimating and valuing presenteeism does
currently not exist and therefore only a crude estimate
of presenteeism costs could have been provided.
For our estimation of productivity loss we did not take
into account hours worked in unpaid employment,
which was a fourth limitation. This may have led to an
overestimation of the actual productivity loss in both
groups. However, only self-reported information about
work resumption in unpaid labor was available and this
was often incomplete. Therefore, the number of hours
worked in unpaid employment could not be assessed
properly. Moreover, because sick-listed workers without
an employment contract are more often low-skilled and
have less work experience compared to sick-listed em-
ployees [40], they may also be less productive compared
to other employees. Therefore, the estimated price of
productivity loss for a Dutch worker per hour, based on
sex and age that was used to value productivity loss,
possibly also resulted in an overestimation of productiv-
ity loss. Nevertheless, because an overestimation of
productivity loss probably took place in both groups, we
were still able to compare productivity loss between
these groups.
Finally, a very large number of sick-listed workers
was sent an invitation for participation in this study
(N = 9822) to reach those sick-listed workers with
mental health problems, because it was not possible
to select potential participants based on a registered
mental health problem. This recruitment procedure
could be considered as a limitation of this study. We
do not know how many sick-listed workers of those
who did not respond to the questionnaire (N = 8058)
actually were sick-listed due to a CMD. Still, we can as-
sume that among this group there were sick-listed workers
who actually would have met the criteria for eligibility.
The large number of non-responders and the large num-
ber of sick-listed workers who responded to the invitation
but were not willing to participate (N = 941), indicate that
selection bias may have played a role. Possibly, sick-listed
workers who participated in this study were more willing
to (actively) participate in the new program, compared to
the ones who did not. The possibility of selection bias
could further complicate generalizing the results of this
study to other settings, and is therefore an important
limitation.
Conclusions
The participatory supportive RTW program was nei-
ther cost-effective in improving sustainable RTW nor
in gaining QALYs from the societal perspective. Also,
from the perspective of the SSA, the program did not
result in a positive financial return. Based on the re-
sults of this study, we cannot recommend implement-
ing the participatory supportive RTW program in the
Dutch social security sector.
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